Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$328.13+3.37 (+1.04%)
Close on Nov 13, 2026Market cap $9.16BP/E –Yield –
Praxis Precision Medicines operating margin
Operating margin is operating income as a percentage of revenue.
Praxis Precision Medicines's operating margin for the twelve months ending Sep 30, 2025 was -3927.5%. For fiscal 2024 it was -2340.3%, against -5164.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -2340.3% | +2824.1 |
| FY2023 | Dec 31, 2023 | -5164.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -857.0% | +4542.2 |
| Q3 FY2024 | Sep 30, 2024 | -18819.5% | −13367.4 |
| Q2 FY2024 | Jun 30, 2024 | -10500.8% | −6024.5 |
| Q1 FY2024 | Mar 31, 2024 | -9718.3% | −4141.3 |
| Q4 FY2023 | Dec 31, 2023 | -5399.2% | – |
| Q3 FY2023 | Sep 30, 2023 | -5452.1% | – |
| Q2 FY2023 | Jun 30, 2023 | -4476.3% | – |
| Q1 FY2023 | Mar 31, 2023 | -5577.0% | – |
See a number that looks wrong?